BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 20479383)

  • 1. Prognostic impact of p16, p53, epidermal growth factor receptor, and human papillomavirus in oropharyngeal cancer in a betel nut-chewing area.
    Al-Swiahb JN; Huang CC; Fang FM; Chuang HC; Huang HY; Luo SD; Chen CH; Chen CM; Chien CY
    Arch Otolaryngol Head Neck Surg; 2010 May; 136(5):502-8. PubMed ID: 20479383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
    Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rising incidence of HPV positive oropharyngeal cancer in Taiwan between 1999 and 2014 where betel nut chewing is common.
    Wang CP; Chen TC; Hsu WL; Hsiao JR; Chen PR; Chen MK; Hua CH; Tsai MH; Ko JY; Lou PJ; Chiang CJ; Wu CT; Chang YL
    BMC Cancer; 2022 Mar; 22(1):296. PubMed ID: 35313837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus in oropharyngeal squamous cell carcinomas in Korea: use of G1 cycle markers as new prognosticators.
    Park WS; Ryu J; Cho KH; Choi MK; Moon SH; Yun T; Chun BS; Lee GK; Ahn HJ; Lee JH; Vermeer P; Jung YS
    Head Neck; 2012 Oct; 34(10):1408-17. PubMed ID: 22052559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.
    Rischin D; Young RJ; Fisher R; Fox SB; Le QT; Peters LJ; Solomon B; Choi J; O'Sullivan B; Kenny LM; McArthur GA
    J Clin Oncol; 2010 Sep; 28(27):4142-8. PubMed ID: 20697079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV status of oropharyngeal cancer by combination HPV DNA/p16 testing: biological relevance of discordant results.
    Hong A; Jones D; Chatfield M; Lee CS; Zhang M; Clark J; Elliott M; Harnett G; Milross C; Rose B
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S450-8. PubMed ID: 23208131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic stratification of oropharyngeal cancer patients in a betel nut chewing and low HPV area.
    Lee HP; Lee CC
    J Otolaryngol Head Neck Surg; 2023 Apr; 52(1):27. PubMed ID: 37081578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different protein expression associated with chemotherapy response in oropharyngeal cancer according to HPV status.
    Kim MJ; Ki MS; Kim K; Shim HJ; Hwang JE; Bae WK; Chung IJ; Lee DH; Lee JK; Yoon TM; Lim SC; Chung WK; Jeong JU; Lim HS; Choi YD; Cho SH
    BMC Cancer; 2014 Nov; 14():824. PubMed ID: 25380690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.
    Patel KR; Chernock RD; Zhang TR; Wang X; El-Mofty SK; Lewis JS
    Hum Pathol; 2013 Nov; 44(11):2385-92. PubMed ID: 24071016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the concordance between p16 immunohistochemistry and HPV-PCR genotyping for the viral diagnosis of oropharyngeal squamous cell carcinoma.
    Fonmarty D; Cherrière S; Fleury H; Eimer S; Majoufre-Lefebvre C; Castetbon V; de Monès E
    Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Jun; 132(3):135-9. PubMed ID: 25687724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
    Rampias T; Pectasides E; Prasad M; Sasaki C; Gouveris P; Dimou A; Kountourakis P; Perisanidis C; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
    Ann Oncol; 2013 Aug; 24(8):2124-31. PubMed ID: 23406730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Undifferentiated carcinoma of the oropharynx: a human papillomavirus-associated tumor with a favorable prognosis.
    Carpenter DH; El-Mofty SK; Lewis JS
    Mod Pathol; 2011 Oct; 24(10):1306-12. PubMed ID: 21572403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters.
    Fischer CA; Kampmann M; Zlobec I; Green E; Tornillo L; Lugli A; Wolfensberger M; Terracciano LM
    Ann Oncol; 2010 Oct; 21(10):1961-1966. PubMed ID: 20423915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer.
    Reimers N; Kasper HU; Weissenborn SJ; Stützer H; Preuss SF; Hoffmann TK; Speel EJ; Dienes HP; Pfister HJ; Guntinas-Lichius O; Klussmann JP
    Int J Cancer; 2007 Apr; 120(8):1731-8. PubMed ID: 17236202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p16
    Brauswetter D; Birtalan E; Danos K; Kocsis A; Krenacs T; Timar J; Mihalyi R; Horcsik D; Polony G; Tamas L; Petak I
    Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1959-1965. PubMed ID: 27999998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults.
    Windon MJ; D'Souza G; Rettig EM; Westra WH; van Zante A; Wang SJ; Ryan WR; Mydlarz WK; Ha PK; Miles BA; Koch W; Gourin C; Eisele DW; Fakhry C
    Cancer; 2018 Jul; 124(14):2993-2999. PubMed ID: 29710393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer.
    Kumar B; Cordell KG; Lee JS; Worden FP; Prince ME; Tran HH; Wolf GT; Urba SG; Chepeha DB; Teknos TN; Eisbruch A; Tsien CI; Taylor JM; D'Silva NJ; Yang K; Kurnit DM; Bauer JA; Bradford CR; Carey TE
    J Clin Oncol; 2008 Jul; 26(19):3128-37. PubMed ID: 18474878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus infection and biomarkers in sinonasal inverted papillomas: clinical significance and molecular mechanisms.
    Scheel A; Lin GC; McHugh JB; Komarck CM; Walline HM; Prince ME; Zacharek MA; Carey TE
    Int Forum Allergy Rhinol; 2015 Aug; 5(8):701-7. PubMed ID: 26077310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.